{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:51:18Z","timestamp":1792032678170,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.pep.2003.09.003","type":"journal-article","created":{"date-parts":[[2003,10,28]],"date-time":"2003-10-28T03:10:31Z","timestamp":1067310631000},"page":"123-133","source":"Crossref","is-referenced-by-count":42,"title":["Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials"],"prefix":"10.1016","volume":"33","author":[{"given":"Jeffrey O","family":"Urieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TieFu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer H","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley A","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C","family":"Willingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis K","family":"Pennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna E","family":"Hogge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Kreitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur E","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2003.09.003_BIB1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","article-title":"Cancer statistics, 2003","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl. 11","key":"10.1016\/j.pep.2003.09.003_BIB2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/(SICI)1097-0142(19971201)80:11+<2205::AID-CNCR7>3.3.CO;2-X","article-title":"Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group Experience","volume":"80","author":"Bennett","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.pep.2003.09.003_BIB3","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1182\/blood.V93.9.3149","article-title":"Effect of complete remission on survival of patients with acute myelogenous leukemia receiving first salvage therapy","volume":"93","author":"Vey","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.pep.2003.09.003_BIB4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00062752-200301000-00006","article-title":"Update in childhood acute myeloid leukemia: recent developments in the molecular basis of disease and novel therapies","volume":"10","author":"Clark","year":"2003","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.pep.2003.09.003_BIB5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.leu.2402809","article-title":"Is modulation of multidrug resistance a viable strategy for acute myeloid leukemia?","volume":"17","author":"Larson","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.pep.2003.09.003_BIB6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-4615-1173-1_12","article-title":"Mechanisms of drug resistance in AML","volume":"112","author":"Andreef","year":"2002","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.pep.2003.09.003_BIB7","first-page":"1231","article-title":"Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL)","volume":"18","author":"Sauerbrey","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/j.pep.2003.09.003_BIB8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/357216a0","article-title":"The crystal structure of diphtheria toxin","volume":"357","author":"Choe","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.pep.2003.09.003_BIB9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/bbrc.2000.3317","article-title":"Molecular characterization of key diphtheria toxin: receptor interactions","volume":"275","author":"Brooke","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pep.2003.09.003_BIB10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1083\/jcb.200210028","article-title":"The cytosolic entry of diphtheria toxin catalytic domain requires the host cell cytosolic translocation factor complex","volume":"160","author":"Ratts","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.pep.2003.09.003_BIB11","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0041-0101(01)00165-9","article-title":"Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century","volume":"39","author":"Collier","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.pep.2003.09.003_BIB12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0076-6879(00)27280-7","article-title":"Fusion protein toxins based on diphtheria toxin: selective targeting of growth factor receptors of eukaryotic cells","volume":"327","author":"vanderSpek","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.pep.2003.09.003_BIB13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/prep.1999.1071","article-title":"High level synthesis and maximal purification of the recombinant diphtheria fusion toxin DTGM for phase I clinical trials","volume":"16","author":"Frankel","year":"1999","journal-title":"Protein Express. Purif."},{"key":"10.1016\/j.pep.2003.09.003_BIB14","first-page":"1004","article-title":"Phase I trial of a novel diphtheria toxin\/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia","volume":"8","author":"Frankel","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pep.2003.09.003_BIB15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1634\/stemcells.21-2-236","article-title":"Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD\/SCID mice","volume":"21","author":"Nitsche","year":"2003","journal-title":"Stem Cells"},{"key":"10.1016\/j.pep.2003.09.003_BIB16","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.leu.2402945","article-title":"Signal transduction mediated by the Ras\/Raf\/MEK\/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention","volume":"17","author":"Chang","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.pep.2003.09.003_BIB17","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood-2002-03-0852","article-title":"Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity and poor prognosis","volume":"100","author":"Testa","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.pep.2003.09.003_BIB18","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","article-title":"The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells","volume":"14","author":"Jordan","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.pep.2003.09.003_BIB19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/protein\/13.8.575","article-title":"Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor","volume":"13","author":"Frankel","year":"2000","journal-title":"Protein Eng."},{"key":"10.1016\/j.pep.2003.09.003_BIB20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.leu.2401743","article-title":"Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias","volume":"14","author":"Frankel","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.pep.2003.09.003_BIB21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0145-2126(01)00034-0","article-title":"High affinity interleukin-3 receptor expression on blasts from patients with acute myelogenous leukemia correlates with cytotoxicity of a diphtheria toxin\/IL-3 fusion protein","volume":"25","author":"Alexander","year":"2001","journal-title":"Leukoc. Res."},{"key":"10.1016\/j.pep.2003.09.003_BIB22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/bc000009q","article-title":"In vitro interleukin-3 binding to leukemia cells predicts cytotoxicity of a diphtheria toxin\/IL-3 fusion protein","volume":"11","author":"Alexander","year":"2000","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.pep.2003.09.003_BIB23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/sj.leu.2402744","article-title":"Diphtheria toxin-interleukin-3 fusion protein (DT388IL3) prolongs disease-free survival of leukemic immunocompromised mice","volume":"17","author":"Black","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.pep.2003.09.003_BIB24","first-page":"1730","article-title":"A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors","volume":"62","author":"Feuring-Buske","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.pep.2003.09.003_BIB25","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1073\/pnas.81.13.4095","article-title":"A structural model of human erythrocyte band 2.1: alignment of chemical and functional domains","volume":"81","author":"Wallin","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pep.2003.09.003_BIB26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.pep.2003.09.003_BIB27","series-title":"A Practical Guide to Protein and Peptide Purification for Microsequencing","author":"Matsudaira","year":"1993"},{"key":"10.1016\/j.pep.2003.09.003_BIB28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.leu.2402084","article-title":"Oncogene-dependent engraftment of human myeloid leukemia cells in immunosuppressed mice","volume":"15","author":"Kiser","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.pep.2003.09.003_BIB29","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1006\/bbrc.2001.5907","article-title":"Receptor binding kinetics of human IL-3 variants with altered proliferative activity","volume":"288","author":"Klein","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104659280300295X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104659280300295X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T09:58:33Z","timestamp":1585216713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104659280300295X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S104659280300295X"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2003.09.003","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}